Goldman Sachs, Credit Suisse, Jefferies, Wells Fargo assist with sale
By Devika Patel
Knoxville, Tenn., Feb. 27 - Lumenis Ltd. said it priced its $75 million initial public sale of stock with an $11.25 million greenshoe. The deal was announced Dec. 9.
The company will sell 6.25 million ordinary B shares at $12.00 apiece.
Goldman Sachs & Co., Credit Suisse Securities (USA) LLC and Jefferies LLC are the joint bookrunning managers.
Settlement is expected March 4.
Proceeds will be used for operations and for other general corporate purposes, including working capital requirements, capital expenditures, investments, research and development, product development and sales and marketing expenditures.
The provider of minimally invasive clinical solutions for surgical, ophthalmic and aesthetic applications is based in Yokneam, Israel. It plans to list its shares on the Nasdaq under the symbol "LMNS."
| Issuer: | Lumenis Ltd.
|
| Issue: | Ordinary B stock
|
| Amount: | $75 million
|
| Greenshoe: | $11.25 million
|
| Shares: | 6.25 million
|
| Price: | $12.00
|
| Warrants: | No
|
| Bookrunners: | Goldman Sachs & Co., Credit Suisse Securities (USA) LLC, Jefferies LLC
|
| Co-manager: | Wells Fargo Securities, LLC
|
| Announcement date: | Dec. 9
|
| Pricing date: | Feb. 27
|
| Settlement date: | March 4
|
| Stock symbol: | Nasdaq: LMNS
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
